Month: November 2020

Nov 13 2020

Uncategorized

Psychiatrist testifies at Matthew Raymond’s murder trial, says accused suffers from schizophrenia

by Clinical Editor

No Comments

Dr. Julian Gojer told jurors that Matthew Raymond’s symptoms escalated in 2017, and that the accused was having delusions and suffering from thought disorder and cognitive impairment …

Nov 12 2020

Uncategorized

Rare and Possibly Life-Threatening Sensitivity to Key Schizophrenia Tx

by Clinical Editor

No Comments

A 22-year-old Hispanic man with schizophrenia is placed on an involuntary hold and admitted to an inpatient psychiatric unit in California after experiencing auditory, visual, and tactile …

Nov 12 2020

Uncategorized

Improving the Design of Clinical Trials of Drugs to Treat Schizophrenia

by Clinical Editor

No Comments

CDER research has identified ways to streamline schizophrenia drug trials without compromising their sensitivity.

Nov 12 2020

Uncategorized

Study uses polygenic risk scores to determine schizophrenia risk in patients with chromosome deletion syndrome

by Clinical Editor

No Comments

A new study involving researchers from Children’s Hospital of Philadelphia (CHOP) has uncovered genetic clues that may help identify which patients with chromosome 22q11.2 deletion syndrome (22q11.2DS …

Nov 12 2020

Uncategorized

Schizophrenia Epidemiology 2017-2030 by Prevalent Cases, Diagnosed Prevalent, Gender, Age, Region

by Clinical Editor

No Comments

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Prevalent Cases of schizophrenia, Diagnosed Prevalent cases of schizophrenia, …

Nov 12 2020

Uncategorized

Psychiatrist testifies at Matthew Raymond’s murder trial, says accused suffers from schizophrenia

by Clinical Editor

No Comments

Dr. Julian Gojer told jurors that Matthew Raymond’s symptoms escalated in 2017, and that the accused was having delusions and suffering from thought disorder and cognitive impairment …

Nov 11 2020

Uncategorized

Speaker: Include LAI antipsychotics in treatment of schizophrenia – Healio

by Clinical Editor

No Comments

Speaker: Include LAI antipsychotics in treatment of schizophrenia  Healio

Nov 11 2020

Uncategorized

Rare and Possibly Life-Threatening Sensitivity to Key Schizophrenia Tx

by Clinical Editor

No Comments

A 22-year-old Hispanic man with schizophrenia is placed on an involuntary hold and admitted to an inpatient psychiatric unit in California after experiencing auditory, visual, and tactile …

Nov 11 2020

Uncategorized

Improving the Design of Clinical Trials of Drugs to Treat Schizophrenia

by Clinical Editor

No Comments

CDER research has identified ways to streamline schizophrenia drug trials without compromising their sensitivity.

Nov 11 2020

Uncategorized

Study uses polygenic risk scores to determine schizophrenia risk in patients with chromosome deletion syndrome

by Clinical Editor

No Comments

A new study involving researchers from Children’s Hospital of Philadelphia (CHOP) has uncovered genetic clues that may help identify which patients with chromosome 22q11.2 deletion syndrome (22q11.2DS …